Treprostinil sodiumProduct ingredient for Treprostinil

Name
Treprostinil sodium
Drug Entry
Treprostinil

Treprostinil is a stable tricyclic analogue of prostacyclin3 that promotes the vasodilation of pulmonary and systemic arterial vascular beds and the inhibition of platelet aggregation.5,6,7 It reduces symptoms in patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease.5,6 The first agent approved for the treatment of PAH was epoprostenol, a synthetic prostacyclin that significantly increases patients' quality of life. However, the use of epoprostenol is limited due to its short half-life (3-5 min) and instability at room temperature.3,4 The use of more stable alternatives such as treprostinil provides patients with PAH with more treatment options.

Treprostinil was approved by the FDA in 2002 for the treatment of pulmonary arterial hypertension.6 It is available in the following routes of administration: subcutaneous, intravenous, inhaled and oral. The first generic form of treprostinil became available in 2019.4

Accession Number
DBSALT002321
Structure
Synonyms
Not Available
UNII
7JZ75N2NT6
CAS Number
289480-64-4
Weight
Average: 412.502
Monoisotopic: 412.22256844
Chemical Formula
C23H33NaO5
InChI Key
IQKAWAUTOKVMLE-ZSESPEEFSA-M
InChI
InChI=1S/C23H34O5.Na/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25;/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27);/q;+1/p-1/t16-,17-,18+,19-,21+;/m0./s1
IUPAC Name
sodium 2-{[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H,2H,3H,3aH,4H,9H,9aH-cyclopenta[b]naphthalen-5-yl]oxy}acetate
SMILES
[Na+].CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2CC3=C(OCC([O-])=O)C=CC=C3C[C@H]12
ChemSpider
5293352
ChEBI
50863
Wikipedia
Treprostinil
Predicted Properties
PropertyValueSource
Water Solubility0.006 mg/mLALOGPS
logP3.92ALOGPS
logP4Chemaxon
logS-4.8ALOGPS
pKa (Strongest Acidic)3.76Chemaxon
pKa (Strongest Basic)-1.3Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area89.82 Å2Chemaxon
Rotatable Bond Count10Chemaxon
Refractivity118.84 m3·mol-1Chemaxon
Polarizability44.92 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon